Stimulation of B and T cells via the antigen receptor, by phorbol ester or by phorbol ester and ionomycin, leads to nuclear translocation of the inducible transcription factor NF-KB, comprising the p50 and p65 re/-related polypeptides. In this report we show that c-tel is a component of the antigen receptor-induced xB binding proteins in both B and T cells. Whereas NF-~cB can be induced by phorbol ester alone, optimal induction of c-tel requires stimulation by both phorbol ester and ionomycin, the dual signal that is necessary for proliferation of untransformed lymphocytes. Furthermore, c-tel induction is blocked by the immunosuppressive drug FK506 that is known to inhibit B and T cell activation, c-rel-dependent transactivation of the interleukin-2 receptor ot chain (Ib2Rot) promoter is augmented by coexpression of calcineurin, suggesting the involvement of a calcineurin-dependent intracellular pathway. Our results identify c-tel as a target of immunosuppressive agents and illustrate the similarity of activation pathways in both B and T ceils.
S
tim. ulation of B and T cells via the antigen receptor triggers a signaling cascade that results in clonal cell proliferation characteristic of the immune response. Alteration of the resting program of gene expression is brought about by inducible nuclear factors that transmit the signal generated at the plasma membrane to the cell nucleus. Several transcription factors have been identified that are induced in response to antigen receptor cross-linking, or its pharmacologic equivalent, the combined action of phorbol esters and calcium ionophore. We, and others, have shown that antigenreceptor cross-linking on both B and T cells induces the factors NF-KB, AP-1, and cAMP response element-binding protein (CREB) (1) (2) (3) (4) . However, these proteins can be induced by the action of phorbol ester alone on these cells, a signal that is not sufficient to induce proliferation. A notable exception is NF-AT, a nuclear factor present in activated T cells, whose induction requires the dual signal of phorbol ester and ionomycin (5) . We have recently shown that both signals are also required to induce an indistinguishable DNA-binding protein in B cells, indicating that NF-AT should be regarded more generally as a factor of activated lymphoid ceils (6) . Because it is likely that proteins that are induced in response to the complete proliferative signal will play a critical role in normal and aberrant immune responses, it is essential to identify factors that satisfy this criterion.
The immunosuppressive drugs cyclosporin A and FKS06 block B and T cell proliferation (7) (8) (9) . The intracellular pathway of drug action in T cells has been recently elucidated. Both drugs bind to distinct cytosolic receptors and the drug receptor complexes inhibit the enzymatic activity of the calcium and cahnodulin-dependent serine/threonine phosphatase, calcineurin (10) (11) (12) (13) . NF-ATp/c, the preexisting cytoplasmic component of NF-AT (14) (15) (16) , has been implicated as a direct target of calcineurin (17, 18) . In this model, calcium-dependent translocation of NF-ATp/c to the nucleus is triggered by dephosphorylation of this protein by calcineurin. In contrast, the mechanism of immunosuppressive action in the B cell compartment is unknown. The observation that slg, but not LPS, mediated B cell proliferation is blocked by these drugs (9, 19) suggests that they interfere with a calcium-dependent pathway, but no nuclear mediators of the effects of immunosuppressive drugs in B cells have been identified. We have recently demonstrated that NF-AT induction in splenic B cells is suppressed by cyclosporin A, indicating that this protein may be partly responsible for the effects of these drugs in B cells (6) . In this report we show that the proto-oncogene c-tel is a component of antigen receptor-induced KB-binding proteins in both B and T cells. Whereas NF-KB (pS0/p65 tel related heterodimer) can be induced by phorbol ester alone, optimal induction of c-tel requires stimulation by both phorbol ester and ionomycin. Furthermore, c-rel induction in both B and T cells is blocked by FK506. The effect of FK506 can be reversed by excess rapamycin, and c-rel-dependent transactivation of the IL-2Rot promoter is augmented by coexpression of calcineurin, suggesting the involvement of a calcineurin-dependent intracel-lular pathway. Our results identify c-tel as a target ofimmunosuppressive action and illustrate the fundamental similarity of activation pathways in B and T cells.
Materials and Methods
Cell Culture and Inductions. The murine B lymphoma cell line Bal 17 was maintained in RPM1 1640 (GIBCO BRL, Gaithersburg, MD) supplemented with 10% heat-inactivated fetal bovine serum, 50/zM B-mercaptoethanol, 50 U/rrd penicillin, and 50 #g/ml streptomycin. CeLls were cultured at a density of 5-6 x 10 s cells/ml during stimulation. Bal 17 B ceils were stimulated for 1-2 h (37~ with 20 ng/ml PMA (Sigma Chemical Co., St. Louis, MO), 20 ng/ml PMA, and 2/~M ionomycin (Calbiochem-Novabiochem Corp., La Jolla, CA) or a~nity-purified goat anti-mouse F(ab')2 fragment, # chain specific, (anti-Ig; Jackson ImmunoResearch Labs., West Grove, PA) at 10-20/~g/ml. D5h3 is a hybridoma derived from Ar-5 cells by fusion with a Tcg-variant of BW 5147 thymorea ceils. DSh3 cells were grown in DMEM medium supplemented with 10% FCS, 2 mM glutamine, 10 mM Hepes, 50 U/m1 penicillin, 50/~g/ml streptomycin, and 50 ~tM B-mercaptoethanol. These cells were stimulated for 4-5 h at a density of 5-6 x 10 s cells/rot. Inducer concentrations were 40 ng/ml PMA, 2 #M ionomycin. D5h3 cells were also activated with cross-linked mAb to murine CD3e. 2Cll (anti-CD3e) antibody was used at 1:100 dilution, and was cross-linked by immobilized rabbit anti-hamster antibody (N. L. Cappel Laboratories, Cochranville, PA) as described previously (2) . FK506, a generous gift from Dr. Stuart Schreiber, (Harvard University, Cambridge, MA) was used at a final concentration of 2 nM where indicated and was added 5-7 rain before addition of other inducing agents.
Nuclear Extracts and Electrophoretic Mobility Shift Assays. Preparation of small scale nuclear extracts from untreated activated cells and labeling of oligonucleotide probes were done as described previously (2). The binding site (H2K) derived from the murine H2K MHC class I gene promoter was isolated as an EcoRI-HindlII fragment from the plasmid subclone (20) and used as a probe. In vitro binding reactions were carried out at room temperature with 6-10 /~gm of nuclear extract for 15 min.
Antibody Shifts and Competitions. For antibody shifts, standard binding reactions were carried out, followed by addition of either rabbit anti c-tel antiserum 1050 gift of Dr. N. Rice (National Cancer Institute, Frederick, MD) (21) or normal rabbit serum (NRS) and overnight incubation on ice. 1-1.5 ~1 of a 1:5 dilution of these antisera were used in 20-#1 binding reactions. For competition assays, where indicated, 1-2/~g of competitor peptides were included in the binding reaction followed by overnight incubation with antibodies as described above. Sequences of the peptides used for com- Induction of c-tel was also directly visualized by Western blot analysis of nuclear extracts (Fig. 1 B) . Nuclear extracts from untreated Bal 17 cells contain detectable levels of c-tel ( Fig. 1 B, lane 1 ) , which were significantly increased by P+I or anti-Ig treatment ( Fig. 1 B, lanes 3 and 4) . PMA treatment alone induced c-tel, albeit at much lower levels ( Fig. 1 B, lane 2) and ionomycin treatment alone had no effect ( Fig. 1 B, compare lanes 5 and 7) . We conclude that optimal induction of DNA-binding c-tel requires anti-Ig stimulation or the dual signals of P+I.
To extend these results, we examined c-tel induction in T cells. Nuclear extracts prepared from DSh3 hybridoma T ceils (26) were used in electrophoretic mobility super-shifr assays (Fig. 1 C) . These T cells contain barely detectable levels of NF-KB in EMSA. Treatment with PMA alone for 4 h resulted in a modest increase of the NF-rB complex, whereas higher levels were seen in cells treated with P+I or anti-CD3 monoclonal antibody (data not shown). Similar to the observation in Bal 17 cells, an additional slower mobility nucleoprotein complex (bold arrow) was observed in the presence of anti-ctel antibody only in extracts from anti-CD3 or P+I-treated cells ( Fig. 1 C, lane 3) . Specificity of the super-shifted complex was assessed by peptide competition assays ( Fig. 1 C,  lanes 4-6) . Inclusion of 1 or 2/zg of peptide used to generate the anti-c-tel antiserum, abolished the super-shifted complex ( Fig. 1 C, lanes 4 and 5) whereas an irrelevant peptide had no effect ( Fig. 1 C, lane 6) . Western blot analysis of nuclear extracts confirmed the c-rel induction pattern seen in EMSA (Fig. 1 D) . Untreated, or PMA-treated, DSh3 cells contained low levels of nuclear c-rel ( Fig. 1/9 , lanes I and 2), which were significantly increased by P+ I or anti-CD3 treatment ( Fig. 1 D, lanes 3 and 4) . In addition, treatment of D5h3 cells with ionomycin alone showed only a slight induction of c-rel (Fig. 1 D, (Fig. 2 A, lanes 3 and 5) . The levels ofc-rel observed with P+ I or anti-Ig were reduced to those seen with PMA alone in the presence of FKS06 (Fig. 2 A, lanes 4 and 6), and the drug had no effect on the low levels of c-tel induced by PMA alone (data not shown Western blot analysis of nuclear c-tel expression in D5h3 (T) cells also showed dramatic reduction of this protein in extracts prepared from cells that were stimulated with P+ I or anti-CD3, in the presence of FKS06 (Fig. 2 B) . Furthermore, optimal c-rel induction in primary adult thymocytes also required the combined action of P+ I, and induction was diminished in the presence of FK506 (33) . We conclude that in both B and T cell lines, signals transduced via the surface receptors are required for optimal induction of nuclear c-rel and that this process is markedly inhibited by CsA and FKS06.
We further confirmed the inhibition of c-rel induction by FKS06 using electrophoretic mobility super-shift assays. In extracts from P+ I-treated Bal 17 cells, an additional supershifted nucleoprotein complex was observed in the presence of anti c-tel antibodies (Fig. 3 A, lane 4) . Consistent with the immunoblotting analysis, this band was not observed when the extracts from P+I-and FK506-treated cells were used in this assay (Fig. 3 A, lane 6) . P+I-treated DSh3 cell extracts also showed a super-shifted nucleoprotein complex indicating the presence of DNA-binding c-tel protein (Fig. 3 B, lane 4). Treatment of DSh3 cells with P+ I in the presence of FKS06 led to a marked reduction of the total induced roB-binding nucleoprotein complex (Fig. 3 B, lanes 5 and 6) , and loss of the anti c-tel-dependent super-shifted complex.
These results suggest either that a large proportion of the KB binding proteins contained c-tel or that induction of other tel family members was also sensitive to FK506 as observed in Jurkat cells (32) .
The sensitivity of other rel family members was further studied by immunoblotting. In both Bal 17 and D5h3 cells, rel B protein was induced to similar levels by treatment with either PMA alone or P+ I (Fig. 4, A and B, lanes 2 and 3 ) , suggesting that a calcium signal was not required for its induction. Consistent with this idea, inclusion of FKS06 during P+I treatment did not affect rel B levels in either cell type (Fig. 4, A and B, lane 4) . PMA-treated HeLa cell extracts were included in these experiments as a positive control (Fig.  4, A and B, lane 5) . Analysis of p50 expression showed no alterations in the levels of this protein in this panel of nuclear extracts (data not shown). These results further indicate that rel proteins are differentially sensitive to the effects of FK506. Rapamycin Reverses FK506 Inhibition of c-tel Induction. Although the major cytosolic receptor for FK506 (FKBP12) is different from that of cyclosporin A (cyclophilin A), both drugs when bound to their intracellular receptors are believed to affect cellular activation by a common mechanism, that is, by inhibiting calcineurin, a Ca2+/calmodulin dependent, and serine/threonine phosphatase. The drug rapamycin competitively inhibits FK506 binding to FKBP12, but the resulting rapamycin/FKBP12 complex does not inhibit calcineurin activity (34, 35) . Therefore, rapamycin reversal of FK506 inhibition has been considered to be an indication of the involvement of calcineurin in the process being studied. To determine whether suppression of c-rel induction by FK506 occurred via the calcineurin pathway, we carried out rapamycin competition experiments (Fig. 5) . In Bal 17 B cells, 2 nM or 0.5 nM FK506 significantly reduced c-rel induction by P+ I (Fig.   1095 Venkataraman et al. Rapamycin was added first to the cell cultures, followed by FK506 10 min hter and then inducers were added after a further 5 min. (B). Western blot analysis of D5h3 nuclear extracts derived from cells treated as indicated, c-tel band is indicated by the arrow. Drugs were added at the same concentrations as described above.
5 A, lanes 3 and 4). A 250-fold molar excess of rapamycin did not affect c-tel induction by P+I (Fig. 5 A, lane 6 ) but completely reversed FK506-dependent inhibition of c-tel induction (Fig. 5 A, lane 5) . The same pattern was true in D5h3 cells. FKS06-mediated inhibition of c-tel induction (Fig.  5 B, lane 4) was significantly diminished in the presence of excess rapamycin (Fig. 5 B, lane 5) . As expected, rapamycin had no effect on the induction of c-tel by P+I (Fig. 5 B, lane  6) . These results strongly suggest a role for calcineurin in c-rel induction in B and T lymphocytes, and identify c-tel as a nuclear target in the calcineurin pathway.
IL 2Rol Gene Induction Is Enhanced by Cakineurin Expression. c-tel has been implicated in the activation of the Ib2R.c~ gene, which is induced in response to mitogenic stimulation of both B and T lymphocytes. Tan et al. (36) showed that overexpression of c-rel in the Jurkat subline J.LEI transactivated a reporter plasmid containing the 5' regulatory region of the IL-2Rcr gene. We have shown that this IL-2Rc~ sequence is optimally activated in non-lymphoid cells by a combination of p50, c-tel and serum response factor (J. Pierce et al., manuscript submitted for publication). To assess whether calcineurin-dependent pathways participate in the generation of transcriptionally active c-tel protein, we assayed the effects of calcineurin expression on the transactivation of an IIr promoter containing reporter plasmid by c-tel. In $194 (plasma) cells, c-tel expression directed by the cytomegalovirus promoter and enhancer was insufficient to activate the reporter plasmid, in the presence or absence of PMA and ionomycin (Fig. 6 A) . Lack of induction by cotransfected c-tel in the presence of PMA and ionomycin may be due to low c-tel expression or inefficient activation of intra-cellular calciumdependent pathways in these terminally differentiated plasma cells. Coexpression of a calcineurin deletion mutant lacking the auto-inhibitory domain (ACaM-AI) resulted in threefold activation of transcription which was further increased by PMA and ionomycin treatment (Fig. 6 A) . Consistent with the proposed role of the auto-inhibitory domain, a cotransfected calcineurin (CN) gene transactivated reporter plasmid expression only in the presence of PMA and ionomycin (Fig.  6 A) . CN-mediated activation of the Ib2Rc~ promoter was diminished by treatment of the transfected cells with FK506 (Fig. 6 A) . These results are consistent with a role for CN in generating transcriptionally active c-tel.
To extend the functional analysis, we examined the effect of CN expression on a cotransfected IL-2Rc~ promoter plasmid in Jurkat T cells. Expression of ACaM-AI alone, transactirated the IL-2Roe promoter 4.5-fold (Fig. 6 B) in these cells. We interpret this to indicate that the presence of the deregulated phosphatase in these cells activated endogenous KBbinding proteins that transactivate the Ib2Rot promoter. Coexpression of c-tel with ACaM-AI increased the expression level of the reporter plasmid, indicating that CN stimulated the transcription activity of transfected c-tel. Note that in the conditions of our assays, neither c-tel alone, nor CN alone, affected Ib2Rot expression (Fig. 6 B) . Furthermore, inducible expression observed in the presence of ACaM-AI was suppressed by FK506. These experiments demonstrate that CN-dependent pathways increase the transcriptional activity of a cotransfected c-rel gene, as well as activate endogenous KB-binding proteins that are necessary for IL-2Rot expression.
Discussion
We have shown that the proto-oncogene c-rel is induced by PMA and ionomycin treatment orb and T lymphoid cells, or by stimulation of cells via the respective antigen receptors. The more sensitive Western blot assay revealed six-to eightfold induction of nuclear c-rel in the B and T cell lines, and DNA-binding c-tel was only detected by antibody super-shift in extracts derived from optimally stimulated cells. The apparent low abundance of the super-shifted complex is likely to be an underestimate of the amount of DNA binding, and therefore presumably functional, nuclear c-rel protein. First, only a fraction of the nuclear c-rel may be bound the H2K-xB probe being used in these assays and second, only a subset of the DNA-bound protein may be super-shifted by the antiserum. In contrast to many other early response genes, such as c-j~s, c-jun, c-myc, and egr-l, which are induced in response to phorbol ester alone, the dual signal requirement for c-rel induction implicates this proto-oncogene as a key participant in lymphocyte proliferation. Cyclosporin A (CsA) and FKS06 inhibit B and T cell proliferation. The effects of these drugs are best characterized in T cells where three different DNA elements have been shown to confer FK506 sensitive transcription activation (14, (35) (36) (37) . However, the mechanism of drug action on the B cell compartment is less clear. We have recently shown that a factor indistinguishable from T cell NF-AT is induced in splenic B cells activated via slg, and that the induction is sensitive to CsA treatment (6) . In this report we show that c-rel induction in both B and T cells is blocked by FK506. Excess rapamycin competed away the FK506 effect, suggesting that c-rel induction requires a CN-dependent intracellular step. Furthermore, neither tel B induction nor p50 expression is sensitive to FK506 suggesting that tel proteins are differentially regulated in lymphocytes.
Unlike NF-AT or octamer-associated protein-1 (OAP-1), NF-KB can be induced by a PMA signal alone. However, higher levels of NF-KB are induced by the combined action of PMA and ionomycin, and CsA or FK506 reduce NF-KB levels to that observed in the presence of PMA alone, suggesting that the drugs affect the Ca2+-dependent NF-KB induction.
Increased NF-xB induction in the presence ofionomycin may occur by translation-dependent (28) or posttranslational mechanisms (32). Frantz et al. have proposed that FK506 inhibition of posttranslational NF-KB induction is caused by disruption of a CN-dependent pathway that normally synergizes with PMA to inactivate I-~Bot (32) . The signaling requirements for c-rel induction that we describe mimic the known properties of NF-AT and OAP-1, and the requirement for ongoing protein synthesis suggests that c-rel may be a part of the translation-dependent NF-xB induction in Jurkat cells (28) .
To show that c-rel suppression by FK506 affects gene expression, we analyzed IL-2Rol gene induction by c-tel. The IL-2Kc~ gene is expressed in activated B and T lymphocytes. The promoter region of this gene contains binding sites for several factors, including a KB site that is essential for the induction of this gene by the HTLV-1 tax gene product and T cell receptor signals (37) (38) (39) . We demonstrate that transactivation of the IL-2Ro~ gene promoter by c-tel is augmented by coexpression of active CN and suppressed by FK506. These results support a role for CN in generating transcriptionally active c-rel and suggest that c-rel suppression by immunosuppressive drugs may be the mechanism by which IL-2Rc~ induction is abolished by these drugs. The characteristics of c-tel induction that we have found are consistent with this protein being a critical, immunosuppressive sensitive, component that is necessary for IL-2Rot expression. We have previously shown that in untransformed T cell clones, the IL-2R~ gene is induced in response to T cell receptor crosslinking and suppressed by CsA (40) . Whereas the NFxB-binding site in the I~2Rc~ promoter (IL-2Rol-B) was necessary for inducible expression of the transfected gene, NF-KB levels detected by EMSA were not significantly affected by CsA treatment of the cells. These observations suggested that the CsA suppressible factor that activates the IL-2Rot promoter is not the bulk KB binding activity detected by EMSA, which is primarily p50/p65 NF-KB. The results presented in this paper suggest that the relatively small proportion of DNA-binding c-rel that is induced by TcR signals may regulate IL-2Rot gene transcription. Suppression of this factor by FK506 inhibits IL-2Ro~ expression without any apparent effect on the induced NF-KB seen in EMSA. Furthermore, induction of II~21~ol mRNA required ongoing protein synthesis. This observation further supports a role for c-tel in activating the IL-2Rc~ promoter, as we have found that c-rel induction in response to PMA and ionomycin requires protein synthesis, whereas NF-KB induction is posttranslational.
Sequence elements homologous to the KB element of the immunoglobulin x gene enhancer are present in a variety of viral and cellular regulatory sequences. For example, several lymphokine genes, such as IL-2, IL-3, II~4, GM-CSF, and TNF-~, whose induction is blocked by FKS06, contain KBrelated sequences in their promoters (41) . Although the specific rel-family members that activate these promoters are not yet known, our results suggest that c-tel may play an important role in the FK506-sensitive expression of these genes. We propose that c-relis a common target ofimmunosuppressive drugs in B and T lymphocytes.
